logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 3
  • 1
    Tommaso Ahmad
    Individual (178 offsprings)
    Insolvency
    2022-11-01 ~ now
    IP - (Case 1) practitioner → CIF 0
  • 2
    Khan, Shareen
    Consultant born in July 1967
    Individual (1 offspring)
    Officer
    2017-03-02 ~ now
    OF - Director → CIF 0
    Ms Shareen Khan
    Born in July 1967
    Individual (1 offspring)
    Person with significant control
    2017-03-02 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
  • 3
    Paul Bailey
    Individual (573 offsprings)
    Insolvency
    2022-11-01 ~ now
    IP - (Case 1) practitioner → CIF 0
parent relation
Company in focus

SK&M PHARMA CONSULTING LIMITED

Period: 2017-03-02 ~ 2023-09-27
Company number: 10646902
Registered name
SK&M PHARMA CONSULTING LIMITED - Dissolved
Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Par Value of Share
Class 1 ordinary share
12019-10-01 ~ 2020-09-30
Debtors
193 GBP2019-09-30
Cash at bank and in hand
90,092 GBP2020-09-30
94,929 GBP2019-09-30
Current Assets
90,092 GBP2020-09-30
95,122 GBP2019-09-30
Creditors
Current
24,788 GBP2020-09-30
28,881 GBP2019-09-30
Net Current Assets/Liabilities
65,304 GBP2020-09-30
66,241 GBP2019-09-30
Total Assets Less Current Liabilities
65,304 GBP2020-09-30
66,241 GBP2019-09-30
Equity
Called up share capital
100 GBP2020-09-30
100 GBP2019-09-30
Retained earnings (accumulated losses)
65,204 GBP2020-09-30
66,141 GBP2019-09-30
Equity
65,304 GBP2020-09-30
66,241 GBP2019-09-30
Average Number of Employees
12019-10-01 ~ 2020-09-30
12018-04-01 ~ 2019-09-30
Other Debtors
Amounts falling due within one year, Current
193 GBP2019-09-30
Other Taxation & Social Security Payable
Current
22,307 GBP2020-09-30
22,307 GBP2019-09-30
Other Creditors
Current
2,481 GBP2020-09-30
6,574 GBP2019-09-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2020-09-30

  • SK&M PHARMA CONSULTING LIMITED
    Info
    Registered number 10646902
    Sussex Innovation, 12-16 Addiscombe Road, Croydon CR0 0XT
    PRIVATE LIMITED COMPANY incorporated on 2017-03-02 and dissolved on 2023-09-27 (6 years 6 months). The status of the company number is Dissolved.
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.